Bio-Ocean
Private Company
Funding information not available
Overview
Bio-Ocean is a privately held, commercial-stage biotechnology supplier operating in the life sciences research tools market. The company leverages a direct-to-researcher and distributor-based business model to provide a broad catalog of immunoassay and molecular biology products, emphasizing affordability and quality assurance. With over two decades of operation, Bio-Ocean has established a global distribution network but appears to be a small-scale player in a highly competitive market dominated by larger corporations. Its strategy focuses on serving the academic and industrial research community with essential reagents.
Technology Platform
Immunoassay development and antibody production for research reagents. Capabilities include ELISA kit design, monoclonal/polyclonal antibody generation, and molecular biology reagent supply.
Opportunities
Risk Factors
Competitive Landscape
Bio-Ocean competes in the highly fragmented and competitive life science reagents market, dominated by giants like Thermo Fisher Scientific, Abcam, Merck Millipore, and Bio-Techne. Its competitive position is as a low-cost, niche alternative, competing on price rather than brand recognition or technological innovation.